Infectious Diseases Update: September 3, 2022
Catch up on all the important news and clinical care topics you may have missed this week.
This past week has had some very important infectious disease news, especially with the mRNA bivalent vaccine boosters getting authorized. Come see what is happening with the news you may have missed from this past week.
The federal agency's recommendation for both the Moderna and the Pfizer-BioNTech updated bivalent vaccines allows people to get the booster dose this fall.
FDA Authorizes mRNA Bivalent COVID-19 Vaccines as Boosters
This Emergency Use Authorization for the Moderna and Pfizer-BioNTech vaccines done in the middle of the week brought them both one step closer for people to become eligible for these boosters.
PrEP Protection Against HIV is Complicated by Chronic HBV
Reviewers weigh evidence for the benefit of oral PrEP protection from HIV with risk of exacerbating hepatitis B.
Most People with HCV Infection Are Not Treated with Direct-Acting Antivirals
A new CDC report underscores a persistent problem of patients not receiving antivirals despite their high curative rate.
With so much going on in this space in terms of gene editing therapies, investigational vaccines, and other modalities, we have developed our new hepatitis section. This section has stories on vaccines and therapies as well as interviews with providers on clinical care in hepatitis.
